Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Poseida Therapeutics	Solid Biosciences	Oyster Point Pharma	Agenus	Precision BioSciences
Symbol	NASDAQ:PSTX	NASDAQ:SLDB	NASDAQ:OYST	NASDAQ:AGEN	NASDAQ:DTIL
Price Information
Current Price	$8.40	$3.49	$16.38	$3.23	$9.50
52 Week Range	Buy	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.6	1.8	0.9	1.6	1.5
Analysis Score	3.5	3.4	0.0	3.5	3.4
Community Score	3.2	2.6	2.2	2.8	2.8
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	2.5	2.5	0.8	0.8
Earnings & Valuation Score	0.6	0.6	0.0	0.6	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$25.00	$12.40	N/A	$8.00	$20.00
% Upside from Price Target	197.62% upside	255.30% upside	N/A	147.68% upside	110.53% upside
Trade Information
Market Cap	$522.10 million	$384.94 million	$425.52 million	$718.48 million	$542.85 million
Beta	N/A	1.1	-0.38	1.86	2.08
Average Volume	339,297	1,446,639	78,687	3,351,813	901,912
Sales & Book Value
Annual Revenue	N/A	N/A	N/A	$150.05 million	$22.24 million
Price / Sales	N/A	N/A	N/A	4.79	24.41
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	N/A	$1.74 per share	$6.43 per share	($1.68) per share	$2.72 per share
Price / Book	N/A	N/A	N/A	-1.92	3.49
Profitability
Net Income	N/A	$-117,220,000.00	$-45,710,000.00	$-107,660,000.00	$-92,880,000.00
EPS	($6.86)	($2.91)	($9.97)	($0.80)	($1.91)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	-192.56%	-484.81%
Return on Equity (ROE)	N/A	-194.22%	-39.61%	N/A	-105.74%
Return on Assets (ROA)	N/A	-140.40%	-37.68%	-97.02%	-53.08%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.03%	N/A	N/A	N/A
Current Ratio	N/A	1.84%	22.78%	0.85%	2.92%
Quick Ratio	N/A	1.84%	22.78%	0.85%	2.92%
Ownership Information
Institutional Ownership Percentage	41.09%	42.73%	70.16%	53.35%	48.57%
Insider Ownership Percentage	19.03%	31.20%	36.90%	4.70%	14.30%
Miscellaneous
Employees	206	70	62	359	231
Shares Outstanding	62.16 million	110.30 million	25.98 million	222.44 million	57.14 million
Next Earnings Date	8/19/2021 (Estimated)	8/5/2021 (Estimated)	8/4/2021 (Estimated)	8/5/2021 (Estimated)	8/12/2021 (Estimated)
Optionable	Not Optionable	Optionable	Not Optionable	Optionable	Not Optionable

Source	Headline
	Derek Jantz Sells 9,676 Shares of Precision BioSciences, Inc. (NASDAQ:DTIL) Stock americanbankingnews.com - May 14 at 7:34 PM
	Precision BioSciences (NASDAQ:DTIL) Announces Quarterly Earnings Results, Beats Expectations By $0.17 EPS americanbankingnews.com - May 14 at 5:42 PM
	Precision BioSciences (NASDAQ:DTIL) Shares Gap Down to $9.27 americanbankingnews.com - May 14 at 11:32 AM
	BRIEF-Precision Biosciences Reports Q1 Loss Per Share Of $0.33 msn.com - May 13 at 10:20 PM
	Precision BioSciences: Q1 Earnings Snapshot sfgate.com - May 13 at 11:02 AM
	Precision BioSciences: Q1 Earnings Snapshot \| Raleigh News & Observer newsobserver.com - May 13 at 11:02 AM
	ICC Precision Manufacturing Program receives $12,500 grant news.yahoo.com - May 12 at 5:56 PM
	ICC Precision Manufacturing Program receives $250K grant news.yahoo.com - May 12 at 12:56 PM
	Precision Livestock Farming Market Will Hit Big Revenues In Future \| Dairymaster, DeLaval, GEA Group, Allflex openpr.com - May 12 at 12:56 PM
	Army’s Precision Strike Missile breaks range record marinecorpstimes.com - May 12 at 12:56 PM
	Precision Camshaft looking for partners for electric vehicle ride msn.com - May 12 at 2:55 AM
	Ensinger Precision Components to invest in automation plasticsnews.com - May 11 at 9:48 PM
	Precision BioSciences, Inc. (NASDAQ:DTIL) CEO Matthew R. Kane Sells 9,746 Shares americanbankingnews.com - May 11 at 5:40 PM
	Insider Selling: Precision BioSciences, Inc. (NASDAQ:DTIL) CEO Sells 9,742 Shares of Stock americanbankingnews.com - May 11 at 5:40 PM
	High Precision Tools Market to Witness Huge Growth by 2026 : Bosch, Komatsu, Haas Automation sbwire.com - May 11 at 4:47 PM
	Praxis Precision Medicines Announces Proposed Public Offering of Common Stock apnews.com - May 11 at 4:47 PM
	Ensinger Precision Components adds presses, robots plasticsnews.com - May 11 at 4:47 PM
	Why Precision BioSciences Stock Is Trading Higher Today msn.com - May 11 at 4:47 PM
	Precision BioSciences Shares Move Higher As ARCUS Platform Shows Promising Gene Editing Approach For Transthyretin Amyloidosis finance.yahoo.com - May 11 at 4:47 PM
	Dell squeezed powerful graphics into its new Precision mobile workstations msn.com - May 11 at 11:47 AM
	New Preclinical Data Presented at the 2021 American Society of Genetic & Cell Therapy Annual Meeting Highlights Precision BioSciences’ ARCUS In Vivo Genome Editing finance.yahoo.com - May 11 at 11:47 AM
	321 Precision nears first A321-200PCF delivery, more conversions to begin in June flightglobal.com - May 10 at 7:04 PM
	Dell's new Precision workstations pack power from the latest from Intel, NVIDIA, and AMD msn.com - May 10 at 2:03 PM
	Precision Proco Switches to Eco Ranges from CMYUK whattheythink.com - May 10 at 9:02 AM
	Precision Thin Film Chip Resistors Market to Increase Exponentially During 2027 reportsgo.com - May 9 at 10:18 PM

Date	Company	Brokerage	Action
12/7/2020	Poseida Therapeutics	William Blair	Reiterated Rating
8/4/2020	Poseida Therapeutics	Bank of America	Initiated Coverage
8/4/2020	Poseida Therapeutics	Piper Sandler	Initiated Coverage
3/22/2021	Solid Biosciences	SVB Leerink	Upgrade
3/22/2021	Solid Biosciences	Credit Suisse Group	Boost Price Target
3/22/2021	Solid Biosciences	Chardan Capital	Boost Price Target
3/15/2021	Solid Biosciences	Barclays	Initiated Coverage
5/21/2020	Solid Biosciences	Nomura	Reiterated Rating
12/18/2019	Solid Biosciences	Nomura Securities	Boost Price Target
10/11/2019	Solid Biosciences	Evercore ISI	Initiated Coverage
8/29/2019	Solid Biosciences	Citigroup	Downgrade
10/27/2020	Oyster Point Pharma	Lifesci Capital	Reiterated Rating
3/6/2020	Oyster Point Pharma	JPMorgan Chase & Co.	Boost Price Target
11/25/2019	Oyster Point Pharma	Cowen	Initiated Coverage
11/25/2019	Oyster Point Pharma	Piper Jaffray Companies	Initiated Coverage
1/15/2021	Agenus	B. Riley	Reiterated Rating
9/18/2020	Agenus	Jefferies Financial Group	Boost Price Target
3/18/2021	Precision BioSciences	Jonestrading	Reiterated Rating
12/15/2020	Precision BioSciences	HC Wainwright	Reiterated Rating
11/23/2020	Precision BioSciences	Stifel Nicolaus	Boost Price Target
4/2/2020	Precision BioSciences	The Goldman Sachs Group	Downgrade
8/9/2019	Precision BioSciences	BTIG Research	Initiated Coverage

(Data available from 5/16/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources